Cannara Biotech Inc. (TSXV: LOVE)
Canada
· Delayed Price · Currency is CAD 0.680
+0.010 (1.49%)
Nov 21, 2024, 10:41 AM EST
Cannara Biotech Cash Flow Statement
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | May '24 May 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 | 2018 |
| Net Income | 5.32 | 6.95 | 2.31 | -1.53 | -12.48 | -12.32 | Upgrade
|
| Depreciation & Amortization | 5.9 | 4.94 | 3.92 | 2.87 | 2.43 | 0.57 | Upgrade
|
| Other Amortization | 0.52 | 0.26 | 0.18 | 0.2 | 0.18 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.96 | 0.13 | 0.05 | 0.07 | 0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.04 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -0.56 | - | - | - | Upgrade
|
| Stock-Based Compensation | 1.96 | 1.75 | 0.35 | 0.33 | 0.78 | 2.19 | Upgrade
|
| Other Operating Activities | 2.8 | -2.48 | -0.84 | -0.21 | 0.84 | 1.88 | Upgrade
|
| Change in Accounts Receivable | -1.79 | -2.05 | -5.68 | -2.82 | 0.03 | 0.16 | Upgrade
|
| Change in Inventory | -5.83 | -8.33 | -8.23 | -3.37 | -2.47 | -0.19 | Upgrade
|
| Change in Accounts Payable | 3.85 | 5 | 2.28 | 2.45 | 0.51 | 0.94 | Upgrade
|
| Change in Unearned Revenue | 0.01 | 0.16 | 0.12 | 0.19 | 0.56 | - | Upgrade
|
| Change in Other Net Operating Assets | -0.87 | -0.9 | 0.02 | -0.27 | 0.25 | -0.66 | Upgrade
|
| Operating Cash Flow | 9.91 | 5.44 | -6.08 | -2.09 | -9.32 | -7.41 | Upgrade
|
| Capital Expenditures | -8.76 | -9.88 | -15.47 | -31.07 | -9.18 | -23.01 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.22 | 0.19 | 0.06 | 0.22 | 0.04 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -0.13 | -0.28 | Upgrade
|
| Other Investing Activities | 0.17 | 0.21 | 0.06 | 0.03 | 0.72 | 1.65 | Upgrade
|
| Investing Cash Flow | -6.37 | -9.48 | -15.35 | -30.83 | -8.55 | -21.64 | Upgrade
|
| Short-Term Debt Issued | - | 3 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 61.88 | 10.7 | 6 | - | Upgrade
|
| Total Debt Issued | 7.2 | 3 | 61.88 | 10.7 | 6 | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.24 | -34.3 | -0.62 | -6.56 | -0.24 | Upgrade
|
| Net Debt Issued (Repaid) | 2.59 | 0.76 | 27.58 | 10.08 | -0.56 | -0.24 | Upgrade
|
| Issuance of Common Stock | - | 0.05 | 0.05 | 24.66 | 0.78 | 39.63 | Upgrade
|
| Repurchase of Common Stock | -0.48 | -0.37 | - | - | - | - | Upgrade
|
| Other Financing Activities | -4.21 | -4.15 | -2.17 | -1.49 | -1.13 | 3.27 | Upgrade
|
| Financing Cash Flow | -2.1 | -3.72 | 25.46 | 33.25 | -0.91 | 42.66 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.08 | -0.08 | 0.06 | 0.06 | -0.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0.01 | Upgrade
|
| Net Cash Flow | 1.44 | -7.84 | 3.96 | 0.39 | -18.73 | 13.61 | Upgrade
|
| Free Cash Flow | 1.15 | -4.44 | -21.55 | -33.17 | -18.51 | -30.42 | Upgrade
|
| Free Cash Flow Margin | 1.50% | -7.76% | -60.11% | -194.86% | -725.49% | -1450.77% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.05 | -0.25 | -0.43 | -0.26 | -0.49 | Upgrade
|
| Cash Interest Paid | 4.03 | 4.09 | 1.19 | 1.32 | 1.02 | 1.38 | Upgrade
|
| Levered Free Cash Flow | -10.36 | -11.52 | -23.81 | -33.71 | -17.66 | -24.56 | Upgrade
|
| Unlevered Free Cash Flow | -7.74 | -8.95 | -22.6 | -32.68 | -16.85 | -23.62 | Upgrade
|
| Change in Net Working Capital | 12.63 | 13.09 | 14.42 | 4.99 | 3.42 | -3.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.